IL83755A - Immunological carrier complex comprising rotavirus nucleocapsid protein vp6 as immunological carrier - Google Patents

Immunological carrier complex comprising rotavirus nucleocapsid protein vp6 as immunological carrier

Info

Publication number
IL83755A
IL83755A IL83755A IL8375587A IL83755A IL 83755 A IL83755 A IL 83755A IL 83755 A IL83755 A IL 83755A IL 8375587 A IL8375587 A IL 8375587A IL 83755 A IL83755 A IL 83755A
Authority
IL
Israel
Prior art keywords
immunological carrier
rotavirus
carrier
nucleocapsid protein
immunological
Prior art date
Application number
IL83755A
Other languages
English (en)
Other versions
IL83755A0 (en
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of IL83755A0 publication Critical patent/IL83755A0/xx
Publication of IL83755A publication Critical patent/IL83755A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6075Viral proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/62Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL83755A 1986-09-03 1987-09-02 Immunological carrier complex comprising rotavirus nucleocapsid protein vp6 as immunological carrier IL83755A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90322286A 1986-09-03 1986-09-03

Publications (2)

Publication Number Publication Date
IL83755A0 IL83755A0 (en) 1988-02-29
IL83755A true IL83755A (en) 1993-04-04

Family

ID=25417135

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83755A IL83755A (en) 1986-09-03 1987-09-02 Immunological carrier complex comprising rotavirus nucleocapsid protein vp6 as immunological carrier

Country Status (10)

Country Link
EP (1) EP0259149B1 (de)
JP (1) JPS63218627A (de)
AT (1) ATE98493T1 (de)
AU (1) AU608769B2 (de)
CA (1) CA1319101C (de)
DE (1) DE3788475T2 (de)
DK (1) DK171602B1 (de)
ES (1) ES2060603T3 (de)
IE (1) IE61417B1 (de)
IL (1) IL83755A (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086880A (en) * 1985-12-26 2000-07-11 The University Of Saskatchewan Rotavirus peptide compositions and methods of use
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
GB9000143D0 (en) * 1990-01-04 1990-03-07 Natural Environment Res Test kit and method for the diagnosis of bluetongue
US5298244A (en) * 1990-10-25 1994-03-29 University Of Saskatchewan Assembled viral particles and their use in a vaccine to rotaviral disease
US5431899A (en) * 1991-02-04 1995-07-11 University Of Saskatchewan Rotavirus VP6 as a diagnostic and targeting agent
DE69213030D1 (de) * 1991-02-04 1996-09-26 Univ Saskatchewan Arzneistoffabgabe aus VP6-Kapseln
WO1994026306A1 (en) 1993-05-12 1994-11-24 Chiron Corporation Conserved motif of hepatitis c virus e2/ns1 region
US5820868A (en) 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US6150137A (en) 1994-05-27 2000-11-21 Ariad Pharmaceuticals, Inc. Immunosuppressant target proteins
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
DE19618797C2 (de) * 1996-05-10 2000-03-23 Bertling Wolf Vehikel zum Transport molekularer Substanz
AU750702B2 (en) * 1997-05-01 2002-07-25 Chiron Corporation Use of virus-like particles as adjuvants
WO1998059063A2 (en) 1997-06-23 1998-12-30 University Of Saskatchewan Bovine adenovirus type 3 genome
DE19750354A1 (de) * 1997-11-13 1999-05-27 November Ag Molekulare Medizin Verfahren zur Applikation von Wirkstoffen
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
DE19829005C2 (de) * 1998-06-29 2000-08-31 November Ag Molekulare Medizin Verfahren zum Transport molekularer Substanz in vorgegebene Bereiche eukaryontischer Zellen
US6458586B1 (en) 1998-11-02 2002-10-01 University Of Saskatchewan Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
MXPA01005389A (es) 1998-11-30 2003-03-27 Cytos Biotechnology Ag Presentacion molecular ordenada de antigenos, metodos de preparacion y uso.
US6451319B1 (en) 1999-04-09 2002-09-17 Schering-Plough Veterinary Corporation Recombinant and mutant adenoviruses
US6299882B1 (en) 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
DE19916224C1 (de) 1999-04-10 2000-06-21 November Ag Molekulare Medizin Synthetisches biologisch aktives Molekül
US7396905B1 (en) 1999-05-21 2008-07-08 Mckeon Frank Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
CA2356207C (en) 1999-10-21 2012-10-09 Case Western Reserve University Gene expression profiling of inflammatory bowel disease
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
AU6368901A (en) 2000-05-31 2001-12-11 Univ Saskatchewan Modified bovine adenovirus having altered tropism
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
US7569217B2 (en) 2001-09-24 2009-08-04 University Of Saskatchewan Porcine adenovirus E1 and E4 regions
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7138252B2 (en) 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
CA2487849A1 (en) 2002-07-18 2004-01-29 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
AU2003255967A1 (en) 2002-07-19 2004-02-09 University Of Saskatchewan Pav regions for encapsidation and e1 transcriptioonal control
EP2338510A1 (de) 2002-07-19 2011-06-29 Novartis Pharma AG Impfstoffzusammensetzungen, die Amyloid-beta1-6 Antigen-Arrays enthalten
WO2004108939A2 (en) 2003-06-10 2004-12-16 University Of Saskatchewan Bav packaging regions and e1 transcriptional control regions
ES2660341T3 (es) 2004-08-26 2018-03-21 The University Of Western Ontario Dianas bacterianas de adquisición de hierro
US8999289B2 (en) 2005-03-22 2015-04-07 President And Fellows Of Harvard College Treatment of protein degradation disorders
PE20061441A1 (es) 2005-05-12 2007-01-18 Novartis Ag Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia
WO2007059166A2 (en) 2005-11-14 2007-05-24 Weber Georg F Peptide sequence that promotes tumor invasion
US8222423B2 (en) 2006-02-14 2012-07-17 Dana-Farber Cancer Institute, Inc. Bifunctional histone deacetylase inhibitors
US8304451B2 (en) 2006-05-03 2012-11-06 President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
KR20140120946A (ko) 2007-08-03 2014-10-14 베링거 인겔하임 베트메디카 게엠베하 브라키스피라 하이오디센테리애의 유전자와 단백질 및 이의 용도
GB0720250D0 (en) 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
EP2363407A1 (de) 2008-02-28 2011-09-07 Murdoch University Neuartige Brachyspira-Sequenzen, immunogene Zusammensetzungen, Herstellungsverfahren dafür und Verwendung davon
EP2271664A4 (de) 2008-03-27 2011-11-23 Prionics Ag Neue sequenzen von brachyspira, immunogene zusammensetzung, herstellungsverfahren und anwendung davon
AU2009274549B2 (en) 2008-07-23 2014-05-01 Dana-Farber Cancer Institute, Inc. Deacetylase inhibitors and uses thereof
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
CN111569056B (zh) * 2020-05-26 2022-09-27 山东信得科技股份有限公司 一种猪轮状病毒疫苗、制备该疫苗的抗原及其编码序列

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235391B1 (de) * 1985-12-26 1992-06-10 The University of Saskatchewan Den antigenischen und immunogenischen Determinanten von wichtigen neutralisierenden Proteinen des Rotavirus entsprechende Peptide
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

Also Published As

Publication number Publication date
DK171602B1 (da) 1997-02-17
ATE98493T1 (de) 1994-01-15
DE3788475T2 (de) 1994-04-07
DK460387A (da) 1988-03-04
IE872353L (en) 1988-03-03
JPS63218627A (ja) 1988-09-12
CA1319101C (en) 1993-06-15
DK460387D0 (da) 1987-09-03
DE3788475D1 (de) 1994-01-27
IE61417B1 (en) 1994-11-02
ES2060603T3 (es) 1994-12-01
IL83755A0 (en) 1988-02-29
AU7791887A (en) 1988-03-10
EP0259149B1 (de) 1993-12-15
EP0259149A2 (de) 1988-03-09
EP0259149A3 (en) 1989-05-24
AU608769B2 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
IL83755A (en) Immunological carrier complex comprising rotavirus nucleocapsid protein vp6 as immunological carrier
AU546390B2 (en) Polishing composition
CA1016008A (en) Process for bland, soluble protein
FI874287A7 (fi) Uudet lymfokiinipeptidit.
HU895836D0 (en) Process for the preparation of carrier proteins
EP0295645A3 (de) Methode zur Reinigung von Faktor VIII:C, von Willebrand-Faktor und Komplexen davon
AU1527188A (en) Factor viii binding domain of von willebrand factor
FI891916A0 (fi) Polypeptider i huggormsgift och genetisk expression av dem.
DE3779711D1 (en) Simultaneous solid-phase synthesis of different peptide(s)
EP0179412A3 (de) Antigen-Peptidverbindungen
GR78104B (de)
AU527557B2 (en) High efficiency catalyst for polymerising olefins
NO865179D0 (no) Fremgangsmaate for fremstilling av 2-klor-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo(d,g)(1,3,6)dioxazociner.
IT1126709B (it) Procedimento di candeggio ottico per substrati costituiti,in parte o in totalita',da poliammidi sintetiche
GR3006212T3 (de)
SE9402253D0 (sv) Process
NO872586D0 (no) Fremgangsmaate for fremstilling av et rekombinant, konjugert protein.
GB1544913A (en) Process for preparing 2,2-bis(3,5-di-t-butyl-4-hydroxy-phenyl)propane
AU525042B2 (en) Ovulation enhancing peptides
Garnizov L’homme, XXV, I (93), janvier-mars, 1985
IL48144A (en) Hexahydro-1h-indolo (2,3-a) quinolizin-5-ium compounds anda process for the praparation thereof
AR242404A1 (es) Nuevos compuestos de niquel bivalente utiles como catalizadores de oligomerizacion de olefinas y procedimiento de preparacion de dichos compuestos.
RO85823B1 (ro) Procedeu pentru prepararea 2, 4-dinamo-(6-hidoxi-metil) pteridinei bromhidrat
ATE69056T1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
SE7800007L (sv) Symmetrisk, halvstyrd stromriktarbrygga

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees